Literature DB >> 6428309

Susceptibilities of enterococci to twelve antibiotics.

R W Tofte, J A Solliday, K B Crossley.   

Abstract

The susceptibilities of 347 urine isolates of enterococci (Streptococcus faecalis, 44%; S. faecalis subsp. zymogenes, 37%; S. faecalis subsp. liquefaciens, 19%) to ampicillin, azlocillin, mezlocillin, piperacillin, vancomycin, gentamicin, erythromycin, rosaramicin, rifampin, rifampin plus trimethoprim (1:4), trimethoprim-sulfamethoxazole (1:20), and chloramphenicol were determined by the agar dilution technique. There were no significant differences in susceptibility to individual agents among the subspecies of S. faecalis. Azlocillin and mezlocillin (MIC for 90% of isolates, 0.78 micrograms/ml) and piperacillin, ampicillin, and vancomycin (MIC for 90% of isolates, 1.56 micrograms/ml) were the most active agents and were significantly more potent than the other reference antibiotics tested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428309      PMCID: PMC185574          DOI: 10.1128/AAC.25.4.532

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

3.  Enterococcal bacteremia without endocarditis.

Authors:  D M Shlaes; J Levy; E Wolinsky
Journal:  Arch Intern Med       Date:  1981-04
  3 in total
  14 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 3.  Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.

Authors:  R C George; A H Uttley
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

4.  Evaluation of MicroScan for identification of Enterococcus species.

Authors:  D M Tritz; P C Iwen; G L Woods
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital.

Authors:  I Nachamkin; P Axelrod; G H Talbot; S H Fischer; C B Wennersten; R C Moellering; R R MacGregor
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

Review 7.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

8.  Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.

Authors:  A Najjar; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Ampicillin-resistant enterococcal species in an acute-care hospital.

Authors:  S E Oster; V A Chirurgi; A A Goldberg; S Aiken; R E McCabe
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

10.  Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?

Authors:  F L Sapico; H N Canawati; V J Ginunas; D S Gilmore; J Z Montgomerie; W J Tuddenham; R R Facklam
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.